Do uterotonic drugs increase risk of abruptio placentae and eclampsia?
暂无分享,去创建一个
[1] H. Minakami,et al. Risk factors for eclampsia in Japan between 2005 and 2009 , 2012, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[2] C. Berg,et al. Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations , 2012, BMC Pregnancy and Childbirth.
[3] J. Post,et al. Foley catheter versus vaginal prostaglandin E2 gel for induction of labour at term (PROBAAT trial): an open-label, randomised controlled trial , 2011, The Lancet.
[4] H. Groen,et al. Impact of the HYPITAT trial on doctors’ behaviour and prevalence of eclampsia in the Netherlands , 2011, BJOG : an international journal of obstetrics and gynaecology.
[5] Hiroshi Ishikawa,et al. Guidelines for obstetrical practice in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2011 edition , 2011, The journal of obstetrics and gynaecology research.
[6] A. Shiozaki,et al. Comparison of risk factors for placental abruption and placenta previa: Case‐cohort study , 2011, The journal of obstetrics and gynaecology research.
[7] C. Roberts,et al. Amniotic fluid embolism in an Australian population‐based cohort , 2010, BJOG : an international journal of obstetrics and gynaecology.
[8] B. Mol,et al. Induction of Labor Versus Expectant Monitoring for Gestational Hypertension or Mild Preeclampsia After 36 Weeks of Gestation (HYPITAT): a Multicenter, Open-label Randomized Controlled Trial , 2010 .
[9] O. Lapaire,et al. The risk of placental abruption when using prostaglandins for cervical ripening in women with preeclampsia: Comparing misoprostol versus dinoprostone , 2010, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[10] P. Brocklehurst,et al. Incidence and Risk Factors for Amniotic-Fluid Embolism , 2010, Obstetrics and gynecology.
[11] A. Franx,et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial , 2009, The Lancet.
[12] M. Knight,et al. Eclampsia in the United Kingdom 2005 , 2007 .
[13] D. Lewis,et al. Abruptio placentae associated with misoprostol use in women with preeclampsia. , 2005, The Journal of reproductive medicine.
[14] M. Katz,et al. Placental abruption in term pregnancies: clinical significance and obstetric risk factors , 2003, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[15] E. Sheiner,et al. Incidence, obstetric risk factors and pregnancy outcome of preterm placental abruption: a retrospective analysis , 2002, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[16] U. Hanson,et al. ECLAMPSIA IN SWEDEN , 2002, Hypertension in pregnancy.
[17] C. Redman,et al. Eclampsia in the United Kingdom , 1994, BMJ.
[18] L. Shulman. Foley catheter versus vaginal prostaglandin E2 gel for induction of labour at term (PROBAAT trial): an open-label, randomised controlled trial , 2012 .
[19] H. Minakami,et al. Do uterotrophic drugs increase the risk of fatal hemorrhagic brain stroke? , 2011, Journal of perinatal medicine.
[20] B. Mol,et al. 764: Impact of the HYPITAT study on doctors behaviour and eclampsia in The Netherlands , 2011 .
[21] P. Brocklehurst,et al. UK obstetric surveillance system uncovered. , 2005, RCM midwives : the official journal of the Royal College of Midwives.